BERTHELSEN SPENCER R 4
4 · IONIS PHARMACEUTICALS INC · Filed Jun 22, 2023
Insider Transaction Report
Form 4
BERTHELSEN SPENCER R
Director
Transactions
- Exercise/Conversion
Common Stock
2023-06-20$28.47/sh+11,250$320,288→ 140,147 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-06-20−11,250→ 0 totalExercise: $28.47From: 2014-07-01Exp: 2023-06-30→ Common Stock (11,250 underlying)
Holdings
- 70(indirect: by Daughter)
Common Stock
Footnotes (2)
- [F1]Acquired as a result of exercising a stock option that was scheduled to expire on 6/30/2023
- [F2]The reporting person disclaims beneficial ownership of all securities held by his daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.